Eagle Pharmaceuticals, Inc. Patent Applications Rejected
15 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-11-10: Application 18506633; Invention FULVESTRANT FORMULATIONS; Applicant Eagle Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2023-10-31: Application 18498259; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
- 2023-08-22: Application 18236480; Invention PEMETREXED FORMULATIONS; Applicant Eagle Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2023-04-05: Application 18296290; Invention FORMULATIONS OF BENDAMUSTINE; Applicant Eagle Pharmaceuticals, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-11-10 | 18506633 | FULVESTRANT FORMULATIONS | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20240082264A1 | Nageswara R. Palepu | United States | MAEWALL, SNIGDHA |
| 2023-10-31 | 18498259 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20240075013A1 | Nagesh R. Palepu Philip Christopher Buxton | United States United Kingdom | ARNOLD, ERNST V |
| 2023-08-22 | 18236480 | PEMETREXED FORMULATIONS | Eagle Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20230390295A1 | Feng-Jing CHEN Steven L. KRILL | United States United States | |
| 2023-04-05 | 18296290 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230285563A1 | Srikanth Sundaram | United States | IVANOVA, SVETLANA M |
| 2023-04-05 | 18296268 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20230241218A1 | Srikanth Sundaram | United States | IVANOVA, SVETLANA M |
| 2022-10-06 | 17995606 | METHODS OF TREATING CORONAVIRUS INFECTIONS | EAGLE PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20230143775A1 | Adrian HEPNER | United States | CHEN, PO-CHIH |
| 2022-08-30 | 17898984 | PEMETREXED FORMULATIONS | EAGLE PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20220409624A1 | Feng-Jing CHEN Steven L. KRILL | United States United States | VANHORN, ABIGAIL LOUISE |
| 2022-08-30 | 17898637 | PEMETREXED FORMULATIONS | EAGLE PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20220409623A1 | Feng-Jing CHEN Steven L. KRILL | United States United States | VANHORN, ABIGAIL LOUISE |
| 2022-08-30 | 17898558 | PEMETREXED FORMULATIONS | EAGLE PHARMACEUTICALS, INC. | Abandoned -- Failure to Respond to an Office Action | US20230000874A1 | Feng-Jing CHEN Steven L. KRILL | United States United States | VANHORN, ABIGAIL LOUISE |
| 2022-08-15 | 17819726 | FULVESTRANT FORMULATIONS | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220387446A1 | Nageswara R. Palepu | United States | MAEWALL, SNIGDHA |
| 2022-05-10 | 17740990 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220265829A1 | Srikanth Sundaram | United States | IVANOVA, SVETLANA M |
| 2022-02-24 | 17679883 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220323584A1 | Srikanth Sundaram | United States | IVANOVA, SVETLANA M |
| 2021-12-02 | 17540878 | METHODS OF USING DANTROLENE TO TREAT NERVE AGENT EXPOSURE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20220087980A1 | Adrian HEPNER | United States | LEE, CHIHYI NMN |
| 2021-09-14 | 17474832 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | Srikanth Sundaram | United States | ||
| 2021-08-26 | 17412623 | FORMULATIONS OF BENDAMUSTINE | Eagle Pharmaceuticals, Inc. | Abandoned -- Failure to Respond to an Office Action | US20210393594A1 | Nagesh R. Palepu Philip Christopher Buxton | United States United Kingdom | ARNOLD, ERNST V |